InvestSMART

Cellmid Limited (ASX: CDY) - Announcements

- Current share price for CDY : $0.056

ASX company news and announcements for Cellmid Limited (CDY) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Cellmid Limited (CDY) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Cellmid Limited (CDY), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Cellmid Limited (CDY)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
- Change of Director's Interest Notice - Halasz 17 Nov 2016 4:31PM $0.031 $0.056 risen by 80.65%
- Cleansing Statement & Appendix 3B 9 Nov 2016 5:30PM $0.029 $0.056 risen by 93.10%
- USA launch of evolis 3 Nov 2016 10:56AM $0.029 $0.056 risen by 93.10%
- Cleansing Statement and Appendix 3B 2 Nov 2016 4:07PM $0.029 $0.056 risen by 93.10%
- Change of Director's Interest Notice - Halasz 1 Nov 2016 4:23PM $0.030 $0.056 risen by 86.67%
- ASX Market Release - Reinstatement 1 Nov 2016 9:17AM $0.033 $0.056 risen by 69.70%
- Cellmid Capital Raising 1 Nov 2016 9:10AM $0.033 $0.056 risen by 69.70%
- Appendix 4C - quarterly 31 Oct 2016 6:31PM $0.033 $0.056 risen by 69.70%
- Appendix 3B 28 Oct 2016 1:43PM $0.033 $0.056 risen by 69.70%
- Suspension from Official Quotation 28 Oct 2016 9:14AM $0.033 $0.056 risen by 69.70%
- Ceasing to be a substantial holder 27 Oct 2016 11:21AM $0.033 $0.056 risen by 69.70%
- Trading Halt 26 Oct 2016 8:58AM $0.033 $0.056 risen by 69.70%
- Exercise of Options (CDYO) 25 Oct 2016 11:05AM $0.035 $0.056 risen by 60%
- Appendix 3B 21 Oct 2016 3:05PM $0.034 $0.056 risen by 64.71%
- Notice of Annual General Meeting/Proxy Form 19 Oct 2016 11:04AM $0.034 $0.056 risen by 64.71%
- Change of Director's Interest Notice - King 17 Oct 2016 5:59PM $0.034 $0.056 risen by 64.71%
- Change of Director's Interest Notice - Halasz 17 Oct 2016 5:58PM $0.034 $0.056 risen by 64.71%
- Change of Director's Interest Notice - Walton 17 Oct 2016 5:57PM $0.034 $0.056 risen by 64.71%
- Change of Director's Interest Notice - Gordon 17 Oct 2016 5:57PM $0.034 $0.056 risen by 64.71%
- CELLMID RECORDS HIGHEST EVER QUARTERLY SALES FOR EVOLIS 10 Oct 2016 11:00AM $0.033 $0.056 risen by 69.70%
- Midkine Antibodies Show Anti-Tumor Activity In Brain Cancer 5 Oct 2016 11:08AM $0.032 $0.056 risen by 75%
- Cellmid 2016 Annual Report to Shareholders 29 Sep 2016 6:02PM $0.031 $0.056 risen by 80.65%
- Quotation of Listed Options (CDYO) 28 Sep 2016 4:04PM $0.030 $0.056 risen by 86.67%
- Expiry Of Listed Options (CDYO) 23 Sep 2016 10:09AM $0.030 $0.056 risen by 86.67%
- European Midkine Patent For Surgical Adhesion Allowed 22 Sep 2016 10:18AM $0.029 $0.056 risen by 93.10%

326 - 350 of 530 results

Page 14 of 22

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.